Xeris Biopharma
topline results of phase study of | Xeris Biopharma
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
2 of 11
Related slides by other companies
Ocuphire Pharma
Results
March 2021
topline phase results randomized parallel arm double masked placebo controlled study of the safety and efficacy of ophthalmic solution to reverse pharmacologically induced mydriasis in healthy subjects | Ocuphire Pharma
argenx SE
Investor Presentation
November 2023
together we discover | argenx SE
Ocuphire Pharma
Results
March 2022
topline phase results | Ocuphire Pharma
ATAI
Investor Presentation
June 2020
phase a study showed wide spread beneficial changes | ATAI
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights